Pakistan Science Abstracts
Choose Theme
1
2
3
4
Theme 1
— Green & Gold
Print
Save as PDF
Export BibTeX
Close
No Detail Found!
Home
›
Annals of Punjab Medical College
Rifaximin Therapy in Patients of Irritable Bowel Syndrome Without Constipation Randomized Controlled Trial
Author(s)
Ghulam Abbas Tahir
FMU/Allied Hospital, Faisalabad, Pakistan
Muhammad Zeeshan Aslam
Medical College, Faisalabad, Pakistan
Zernab
Teaching Hospital, Faisalabad, Pakistan
Zaheer Ahmad
Hospital, Lahore, Pakistan
Abstract
Irritable Bowel Syndrome (IBS) is a common condition affecting lives of patients across the globe. The statistics are much worse than previously thought. Studies showed that 9 - 23% of the world population is suffering from IBS. Very few options are available with inadequate efficacy and a dire need for newer options. Rifaximin is one such promising drug. This study has been conducted to determine the efficacy of rifaximin therapy in IBS patients. Objective: The efficacy of rifaximin was compared with a placebo in controlling the symptoms of irritable bowel syndrome. Study design: Randomized Controlled Trial. Setting: Medicine Outpatient Clinical Department, Allied Hospital, Faisalabad. Duration of study: 27-05-2015 to 2611-2015. Sample size: 620 (310 in each group) were enrolled in the study after fulfilling inclusion criteria. Sampling technique: Non-Probability Consecutive Sampling. Results: 620 patients were enrolled in this study. Mean age of study population was 28.31 + 6.45 (Table I). 298 (48.1%) were male and 322 (51.9%) were female. Patients were divided into group A and Group B. Group A received rifaximin and group B received placebo. In group A, improvement in IBS symptoms with Rifaximin was noted in 171 (55.1%) as compared to 90 (29.03%) in group B (p-value <0.0001). Conclusion: Rifaximin is effective in treatment of IBS without constipation. Prescribing rifaximin should be considered in treatment of IBS patients as it provides a promising treatment option which is cost effective and has fewer side effects.
Publication Details
Page(s)
217-221
DOI
10.29054/APMC/17.390
Published
Journal: Annals of Punjab Medical College, Volume: 11, Issue: 3, Year: 2017
Request the full text from PASTIC
Keywords
Irritable bowel syndrome, Rifaximin, Placebo
More from
Annals of Punjab Medical College
Evaluation of Triiodothyronine (T3) and Lipid Peroxidation in Hepatitis C Patients Receiving Interferon and Ribavirin
To Determine the Frequency of Various Factors Leading to Uncontrolled Asthma in Asthmatic Population (>16 Years of Age)
Management of Inguinal Hernia in Children
Knowledge, Attitude and Practices Before and After Dental Health Education among Hearing and Speech Impaired Children
Management of Forgotten Ureteral Double J Stents: Causes and Management
0
Citations
0
Downloads
34
Views